Clinical trial · Observational
Quality of Life of Caregivers Supporting an Older Adult With Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The French population is aging, and the number of newly diagnosed cancers among individuals aged 75 years and older continues to increase. The development of geriatric medicine, and particularly geriatric oncology, in collaboration with surgical and medical oncology specialists, has expanded access to innovative anticancer therapies for older adults. Although these treatments have improved therapeutic options, they are associated with adverse effects that may lead to functional decline and reduced quality of life in older patients. These consequences may also adversely affect the well-being and quality of life of their informal caregivers. The role of informal caregivers has progressively become an integral component of cancer care. It is well established that providing care to a relative with a chronic illness can negatively impact caregivers' physical and psychological health, as well as their quality of life. While older patients are increasingly monitored through specialized geriatric oncology consultations, caregivers rarely receive systematic assessment or follow-up. Understanding the factors associated with caregiver quality of life is therefore essential to improve comprehensive patient-centered care in geriatric oncology. This prospective observational study aims to investigate the association between baseline comprehensive geriatric assessment parameters of older patients with cancer-including functional status, nutritional status, cognition, mood, physical performance, sensory impairment, and comorbidities-and the quality of life of their caregiver. Caregiver quality of life will be assessed using the validated CarGOQoL questionnaire. Patient-caregiver dyads will be followed for six months, corresponding to the usual period for evaluating treatment tolerance and effectiveness. The findings may help identify caregivers at risk of impaired quality of life and support the integration of caregiver assessment into routine geriatric oncology practice.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Caregiver Quality of Life | — | UNRESOLVED | — |
| Geriatric Medicine | — | UNRESOLVED | — |
| Geriatric Oncology | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CarGOQol scale | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Less frail older patient-caregiver dyads
- description
- patients aged 70 years or older with histologically confirmed cancer and their primary informal caregiver of less frail older patients
- interventionNames
- Other: CarGOQol scale
- label
- most frail older patients-caregiver dyads
- description
- patients aged 70 years or older with histologically confirmed cancer and their primary informal caregiver of most frail older patients
- interventionNames
- Other: CarGOQol scale
Primary outcomes (1)
- measure
- To assess whether patient frailty, measured by the G8 screening tool, identifies caregivers at increased risk of poorer quality of life, assessed using the CarGOQoL scale.
- timeFrame
- at inclusion
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria Patient: * Aged 70 years or older. * Attending a first geriatric oncology consultation. * Histologically confirmed diagnosis of cancer. * Accompanied by a primary informal caregiver at the consultation. Caregiver: \- Aged 18 years or older. Dyad: \- The patient and caregiver have been informed about the study and do not object to participation, in accordance with French regulations governing non-interventional research. Exclusion Criteria Patient: * Unable to express non-opposition to participation (e.g., under legal guardianship or presenting severe neurocognitive impairment as assessed during the consultation). * Language barrier preventing study participation when the caregiver is unable to provide adequate interpretation. * Objection to participation. * Not affiliated with the French national health insurance system. * Beneficiary of State Medical Aid Caregiver: * Unable to understand or complete study questionnaires in French. * Clinically significant cognitive impairment identified during the consultation. * Objection to participation.
References
Publications (0)
Data not yet available